Jupiter Asset Management Ltd. Buys 15,142 Shares of Colgate-Palmolive (NYSE:CL)

Jupiter Asset Management Ltd. raised its position in Colgate-Palmolive (NYSE:CLFree Report) by 2.3% during the fourth quarter, Holdings Channel reports. The fund owned 685,718 shares of the company’s stock after acquiring an additional 15,142 shares during the period. Jupiter Asset Management Ltd.’s holdings in Colgate-Palmolive were worth $62,339,000 as of its most recent filing with the SEC.

Other institutional investors have also recently made changes to their positions in the company. Hopwood Financial Services Inc. bought a new stake in Colgate-Palmolive during the 4th quarter valued at approximately $297,000. EverSource Wealth Advisors LLC boosted its holdings in shares of Colgate-Palmolive by 31.9% in the 4th quarter. EverSource Wealth Advisors LLC now owns 4,866 shares of the company’s stock worth $442,000 after purchasing an additional 1,177 shares during the period. Sequoia Financial Advisors LLC boosted its stake in shares of Colgate-Palmolive by 24.0% during the 4th quarter. Sequoia Financial Advisors LLC now owns 25,286 shares of the company’s stock worth $2,299,000 after purchasing an additional 4,894 shares during the period. Moors & Cabot Inc. boosted its position in shares of Colgate-Palmolive by 4.6% during the fourth quarter. Moors & Cabot Inc. now owns 47,516 shares of the company’s stock valued at $4,320,000 after buying an additional 2,081 shares during the period. Finally, Natural Investments LLC purchased a new position in Colgate-Palmolive during the 4th quarter valued at $424,000. Institutional investors own 80.41% of the company’s stock.

Wall Street Analysts Forecast Growth

CL has been the subject of a number of research reports. Stifel Nicolaus lowered their price objective on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a research note on Monday, February 3rd. Royal Bank of Canada reiterated a “sector perform” rating and issued a $101.00 price target on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. JPMorgan Chase & Co. lowered their price target on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a research report on Monday, February 3rd. Morgan Stanley cut their price objective on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a research note on Monday, February 3rd. Finally, Wells Fargo & Company reduced their price target on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research report on Tuesday, January 7th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have assigned a buy rating to the company’s stock. According to MarketBeat, Colgate-Palmolive has a consensus rating of “Moderate Buy” and an average price target of $101.61.

View Our Latest Stock Report on Colgate-Palmolive

Colgate-Palmolive Price Performance

CL stock opened at $94.05 on Wednesday. Colgate-Palmolive has a fifty-two week low of $85.32 and a fifty-two week high of $109.30. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. The stock has a market cap of $76.32 billion, a price-to-earnings ratio of 26.72, a PEG ratio of 4.20 and a beta of 0.40. The business has a 50 day moving average price of $89.03 and a 200 day moving average price of $94.99.

Colgate-Palmolive (NYSE:CLGet Free Report) last announced its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the previous year, the company earned $0.87 earnings per share. Equities research analysts anticipate that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.